ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
AusperBio raised a $120 million Series C for hepatitis B therapeutics, the largest verified round. Other funded startups include CivilGrid, Transfyr, and Yardstik. The market favors financing hard deployment problems over broad technology promises.
Tap to vote and see what everyone thinks.
Summary by ByteBrief